| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Christoph J Griessenauer, Jeffrey D Lebensburger, Michelle H Chua, Winfield S Fisher, Lee Hilliard, Christina J Bemrich-Stolz, Thomas H Howard, James M Johnsto. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease. Journal of neurosurgery. Pediatrics. vol 16. issue 1. 2015-09-28. PMID:25837886. |
the 14 patients with scd and radiological evidence of mms and on chronic transfusion therapy for primary or secondary stroke prevention underwent 21 edas or emas procedures for progressive vascular disease (92.9% of patients), stroke (71.4%), and/or seizure (7.1%). |
2015-09-28 |
2023-08-13 |
Not clear |
| Madu Anazoeze Jude, Galadanci Najiba Aliyu, Aisha Mohammed Nalado, Kangiwa Umar Garba, Fowodu O Florence, Ahmed Hassan, Marcus Inyama, Oluwaseun Akinpelu, Nwagha Theresa, Ibegbulam Obike Godswill, Ocheni Sunday, Emodi Ifeoma, Ikefuna Anthony, Chukwu Batholomew, Okocha E Chide, Orkuma Joseph, Iheanacho Malachy, Kaladada Korubo, Anike Uchenna Sabastine, Agu Kingsley, Charles Nonyelu, Angela Ugwu, Augustin Duru, Chukwudi Anigbo, Alozie Eze, Awele Chukwurah, Uchenna Ololo, Caroline Omoti, Obineche Agwu, Okpala Iheany. Stroke prevalence amongst sickle cell disease patients in Nigeria: a multi-centre study. African health sciences. vol 14. issue 2. 2015-09-18. PMID:25320596. |
stroke is a life-changing, debilitating complication of sickle cell disease (scd). |
2015-09-18 |
2023-08-13 |
Not clear |
| Adetola A Kassim, Najibah A Galadanci, Sumit Pruthi, Michael R DeBau. How I treat and manage strokes in sickle cell disease. Blood. vol 125. issue 22. 2015-08-25. PMID:25824688. |
limited evidence is available to guide acute and chronic management of individuals with scd and strokes. |
2015-08-25 |
2023-08-13 |
Not clear |
| Adetola A Kassim, Najibah A Galadanci, Sumit Pruthi, Michael R DeBau. How I treat and manage strokes in sickle cell disease. Blood. vol 125. issue 22. 2015-08-25. PMID:25824688. |
we will discuss our strategy of acute and long-term management of strokes in scd. |
2015-08-25 |
2023-08-13 |
Not clear |
| Sarah L Reeves, Thomas M Braun, Kevin J Dombkowski, Heather J Fullerton, Matthew L Boulton, Lynda D Lisabet. The role of neighborhoods in the receipt of transcranial Doppler screening among children with sickle cell disease. Journal of pediatric hematology/oncology. vol 37. issue 4. 2015-07-28. PMID:25265467. |
although transcranial doppler (tcd) screening assesses the need for stroke prevention efforts among children with sickle cell disease (scd), screening rates remain low across many parts of the united states. |
2015-07-28 |
2023-08-13 |
Not clear |
| Marisa B Marques, Nirupama Singh, Vishnu V B Redd. Out with the bad and in with the good; red cell exchange, white cell reduction, and platelet reduction. Journal of clinical apheresis. vol 29. issue 4. 2015-04-14. PMID:24828305. |
conversely, other patients with scd undergo rbc exchanges on a chronic basis to maintain a reasonable quality of life and prevent another stroke. |
2015-04-14 |
2023-08-13 |
Not clear |
| Manoelle Kossorotoff, Valentine Brousse, David Grevent, Olivier Naggara, Francis Brunelle, Thomas Blauwblomme, Pascale Gaussem, Isabelle Desguerre, Mariane De Montalember. Cerebral haemorrhagic risk in children with sickle-cell disease. Developmental medicine and child neurology. vol 57. issue 2. 2015-03-03. PMID:25174812. |
to address risk of first or recurrent cerebral haemorrhage in children with sickle-cell disease (scd) who are being managed with modern stroke prevention strategies. |
2015-03-03 |
2023-08-13 |
Not clear |
| IkeOluwa Lagunju, Olugbemiro Sodeinde, Biobele Brown, Felix Akinbami, Babatunde Adedoku. Transcranial Doppler ultrasonography in children with sickle cell anemia: Clinical and laboratory correlates for elevated blood flow velocities. Journal of clinical ultrasound : JCU. vol 42. issue 2. 2014-09-19. PMID:24166013. |
transcranial doppler (tcd) sonography of major cerebral arteries is now recommended for routine screening for stroke risk in children with sickle cell disease (scd). |
2014-09-19 |
2023-08-12 |
Not clear |
| Nicholas A Madden, Gary L Jones, Ram Kalpatthi, Gerald Wood. Practice patterns of stroke screening and hydroxyurea use in children with sickle cell disease: a survey of health care providers. Journal of pediatric hematology/oncology. vol 36. issue 6. 2014-09-11. PMID:24714503. |
incidence of stroke in sickle cell disease (scd) has declined with the use of transcranial doppler ultrasound and chronic transfusion therapy. |
2014-09-11 |
2023-08-13 |
Not clear |
| Nicholas A Madden, Gary L Jones, Ram Kalpatthi, Gerald Wood. Practice patterns of stroke screening and hydroxyurea use in children with sickle cell disease: a survey of health care providers. Journal of pediatric hematology/oncology. vol 36. issue 6. 2014-09-11. PMID:24714503. |
silent cerebral infarcts (scis) have been identified by magnetic resonance imaging (mri) in scd patients and it is believed that these may increase the risk of overt stroke. |
2014-09-11 |
2023-08-13 |
Not clear |
| Esteban Gomez, Claudia R Morri. Asthma management in sickle cell disease. BioMed research international. vol 2013. 2014-07-29. PMID:24324967. |
recent studies confirm that asthma predisposes to complications of scd such as pain crises, acute chest syndrome, and stroke and is associated with increased mortality. |
2014-07-29 |
2023-08-12 |
Not clear |
| Reza Bavarsad Shahripour, Martin M Mortazavi, Kristian Barlinn, Bijan Keikhaei, Hadi Mousakhani, Mahmoud Reza Azarpazhooh, Morteza Oghbaee, Seyed Aidin Sajedi, Jessica Kepplinger, R Shane Tubbs, Karen C Albright, Andrei V Alexandro. Can STOP Trial Velocity Criteria Be Applied to Iranian Children with Sickle Cell Disease? Journal of stroke. vol 16. issue 2. 2014-06-20. PMID:24949316. |
sickle cell disease (scd) is strongly linked to stroke across all haplotypes in the pediatric population. |
2014-06-20 |
2023-08-13 |
Not clear |
| Reza Bavarsad Shahripour, Martin M Mortazavi, Kristian Barlinn, Bijan Keikhaei, Hadi Mousakhani, Mahmoud Reza Azarpazhooh, Morteza Oghbaee, Seyed Aidin Sajedi, Jessica Kepplinger, R Shane Tubbs, Karen C Albright, Andrei V Alexandro. Can STOP Trial Velocity Criteria Be Applied to Iranian Children with Sickle Cell Disease? Journal of stroke. vol 16. issue 2. 2014-06-20. PMID:24949316. |
we aimed to evaluate baseline tcd findings in iranian children with scd and no prior strokes. |
2014-06-20 |
2023-08-13 |
Not clear |
| Prasad Bodas, Seth Rot. Cerebral vascular abnormalities in pediatric patients with sickle cell disease after hematopoietic cell transplant. Journal of pediatric hematology/oncology. vol 36. issue 3. 2014-05-26. PMID:24327127. |
stroke is a common sequela of sickle cell disease (scd). |
2014-05-26 |
2023-08-12 |
Not clear |
| Azza Abdel Gawad Tantawy, Amira Abdel Moneam Adly, Eman Abdel Rahman Ismail, Nevin Mamdouh Habeeb, Amal Farou. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications. Platelets. vol 24. issue 8. 2014-05-14. PMID:23249216. |
mps levels were significantly increased in scd patients with pulmonary hypertension, acute chest syndrome, and stroke as well as those who had history of thrombosis or splenectomy (p < 0.001). |
2014-05-14 |
2023-08-12 |
Not clear |
| Akila Venkataraman, Robert J Adam. Neurologic complications of sickle cell disease. Handbook of clinical neurology. vol 120. 2014-04-22. PMID:24365368. |
magnetic resonance imaging and positron emission tomography give evidence of subtle and sometimes overt brain injury due to stroke in many adults, but a preventive strategy for adults with scd has not been developed. |
2014-04-22 |
2023-08-12 |
Not clear |
| James J DiNicolantonio, Pascal Meier, James H O'Keef. Omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease: do formulation, dosage & comparator matter? Missouri medicine. vol 110. issue 6. 2014-04-17. PMID:24564001. |
multiple trials over the past two decades testing omega-3 polyunsaturated fatty acids (pufas), containing eicosapentaenoic acid (epa) and or docosahexaenoic acid (dha), have shown substantial benefits for reducing major coronary heart disease (chd) events, all-cause mortality, cardiovascular (cv) death, sudden cardiac death (scd), and stroke. |
2014-04-17 |
2023-08-12 |
Not clear |
| Hyacinth I Hyacinth, Robert J Adams, Jenifer H Voeks, Jacqueline M Hibbert, Beatrice E Ge. Frequent red cell transfusions reduced vascular endothelial activation and thrombogenicity in children with sickle cell anemia and high stroke risk. American journal of hematology. vol 89. issue 1. 2014-03-26. PMID:23996496. |
beyond improving hemoglobin levels, our results suggest that the protective effects of prbc transfusion on reducing stroke in scd may result from reduced thrombogenesis and vascular remodeling. |
2014-03-26 |
2023-08-12 |
human |
| Akram Asbeutah, Renu Gupta, Osama Al-Saeid, Sam Ashebu, Sundus Al-Sharida, Ali Mullah-Ali, Nada Yousef Mustafa, Adekunle Adekil. Transcranial Doppler and brain MRI in children with sickle cell disease and high hemoglobin F levels. Pediatric blood & cancer. vol 61. issue 1. 2014-01-07. PMID:24038756. |
while overt stroke and silent brain infarcts (sbi) are uncommon among kuwaiti patients with sickle cell disease (scd), there have been no previous transcranial doppler (tcd) studies in this population. |
2014-01-07 |
2023-08-12 |
Not clear |
| Paolo Rigano, Alice Pecoraro, Giuseppina Calvaruso, Martin H Steinberg, Sonia Iannello, Aurelio Maggi. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians. American journal of hematology. vol 88. issue 11. 2013-12-24. PMID:23828131. |
stroke is a common cause of morbidity and mortality in sickle cell disease (scd) and silent cerebral infarction is the most common form of neurologic injury. |
2013-12-24 |
2023-08-12 |
Not clear |